5 Key Players in Asia Pacific Pharmaceutical Transport & Logistics 2013Add bookmark
It is an exciting time for the Asia Pacific pharmaceutical transport and logistics market, which has experienced rapid growth despite economic problems in two of its largest trade regions - the EU and the US - and is seeing more opportunities open up in emerging areas such as Africa.
The ongoing development of the industry will be driven by a number of key companies. In this article Cold Chain IQ takes a closer look at 5 key Asian logistics providers:
This Hong Kong-based company has over 600 offices and business centres across six continents and logistics facilities spanning more than three million sq m.
It started 2013 by expanding its network in Vietnam, securing a majority stake in express company Tin Thanh Express.
Kintetsu World Express
Kintetsu World Express traces its history back to the late 1940s and now has a global network encompassing Japan, China, the US, Brazil and many other countries.
The group's recent expansions have included an airport office in Delhi and a warehouse in Ho Chi Minh City.
As well as strengthening its presence in Asia with new branches in Changsha, Tianjin and Shanghai this year, Nippon Express has expanded in other regions with openings such as the Guanajuato logistics centre in central Mexico.
The company has direct operations in 33 nations and annual revenues of over US$14 billion (£9.1 billion).
Sinotrans is one of China's largest logistics providers, with revenues totalling RMB 23.16 billion (£2.4 billion) in the first half of 2012.
It offers a range of integrated logistics services, including freight forwarding, sea, air and road transportation, and storage and terminal operations.
Toll originated as a horse and cart haulage operation in 1888 and now employs over 45,000 people across some 1,200 sites in more than 50 countries.
The company's road transport provider Toll NQX has just invested AU$8.8 million (£6 million) in its fleet.
|Have Your Say|
Rate this feature and give us your feedback in the comments section below